BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 22354325)

  • 1. Oral field cancerization: current evidence and future perspectives.
    Angadi PV; Savitha JK; Rao SS; Sivaranjini Y
    Oral Maxillofac Surg; 2012 Jun; 16(2):171-80. PubMed ID: 22354325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited proliferative oral disorder: a reductionist approach to proliferative verrucous leukoplakia.
    Radhakrishnan R
    Indian J Dent Res; 2011; 22(3):365-6. PubMed ID: 22048571
    [No Abstract]   [Full Text] [Related]  

  • 3. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative verrucous leukoplakia and field cancerization: report of a case.
    Feller L; Wood NH; Raubenheimer EJ
    J Int Acad Periodontol; 2006 Apr; 8(2):67-70. PubMed ID: 16623182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral cancer. The importance of early diagnosis and treatment.
    Sciubba JJ
    Am J Clin Dermatol; 2001; 2(4):239-51. PubMed ID: 11705251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentially Malignant Oral Disorders and Cancer Transformation.
    Ganesh D; Sreenivasan P; Öhman J; Wallström M; Braz-Silva PH; Giglio D; Kjeller G; Hasséus B
    Anticancer Res; 2018 Jun; 38(6):3223-3229. PubMed ID: 29848669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic proliferative verrucous leukoplakia: report of a clinical rarity.
    Singh AP; Chaitra TR; Kulkarni AU; Jathar PN
    BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22865802
    [No Abstract]   [Full Text] [Related]  

  • 8. Proliferative verrucous leukoplakia: report of a case with characteristic long-term progression.
    Vigliante CE; Quinn PD; Alawi F
    J Oral Maxillofac Surg; 2003 May; 61(5):626-31. PubMed ID: 12730844
    [No Abstract]   [Full Text] [Related]  

  • 9. Proliferative verrucous leukoplakia: report of two cases and a discussion of clinicopathology.
    Greer RO; McDowell JD; Hoernig G
    J Calif Dent Assoc; 1999 Apr; 27(4):300-5, 308-9. PubMed ID: 10528563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral medicine case book 37. Proliferative verrucous leukoplakia.
    Padayachee S; Peck MT; Dreyer WP; Allie A; Afrogheh A
    SADJ; 2012 Mar; 67(2):78-80. PubMed ID: 23189896
    [No Abstract]   [Full Text] [Related]  

  • 11. A genetic progression model of oral cancer: current evidence and clinical implications.
    Braakhuis BJ; Leemans CR; Brakenhoff RH
    J Oral Pathol Med; 2004 Jul; 33(6):317-22. PubMed ID: 15200478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of aberrant p53 and p21(WAF1) immunoreactivity with the outcome of oral verrucous leukoplakia in Taiwan.
    Chang KW; Lin SC; Kwan PC; Wong YK
    J Oral Pathol Med; 2000 Feb; 29(2):56-62. PubMed ID: 10718400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leukoplakia and erythroplakia--two orale precursor lesions].
    Grajewski S; Groneberg D
    Laryngorhinootologie; 2009 Oct; 88(10):666-72; quiz 673-5. PubMed ID: 19813163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the risk factors associated with multiple oral premalignant lesions with a case report of extensive field cancerization in a female patient.
    Sreedhar G; Narayanappa Sumalatha M; Shukla D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):178-83. PubMed ID: 24401899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Abnormalities in Oral Leukoplakia and Oral Cancer Progression.
    Kil TJ; Kim HS; Kim HJ; Nam W; Cha IH
    Asian Pac J Cancer Prev; 2016; 17(6):3001-6. PubMed ID: 27356725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral erythroplakia and erythroleukoplakia: red and red-white dysplastic lesions of the oral mucosa--part 2: cytodiagnosis, pathogenesis, therapy, and prognostic aspects].
    Suter VG; Morger R; Altermatt HJ; Spieler P; Bornstein MM
    Schweiz Monatsschr Zahnmed; 2008; 118(6):510-8. PubMed ID: 18619138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications.
    Wang YP; Chen HM; Kuo RC; Yu CH; Sun A; Liu BY; Kuo YS; Chiang CP
    J Oral Pathol Med; 2009 Sep; 38(8):651-6. PubMed ID: 19656267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Premalignant disorders and cancer of the oral mucosa].
    Reibel J; Holmstrup P
    Ugeskr Laeger; 2010 Nov; 172(44):3040-2. PubMed ID: 21044562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative verrucous leukoplakia: a case report.
    Lopes MA; Pazoki AE; Ord RA
    Gen Dent; 2000; 48(6):708-10. PubMed ID: 12004667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy in proliferative verrucous leukoplakia.
    Klanrit P; Sperandio M; Brown AL; Shirlaw PJ; Challacombe SJ; Morgan PR; Odell EW
    Oral Oncol; 2007 Mar; 43(3):310-6. PubMed ID: 16931117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.